Page Hero

In the News

Coverage of Tisch MSRCNY research, Center updates, and thought leadership from our team.

Press Coverage

See More Press

09.28.2026

Effect of intrathecal injection of mesenchymal stem cell-neural progenitors on cerebrospinal fluid biomarkers in progressive multiple sclerosis (opens in a new tab)

Researchers conduct an experiment

06.05.2024

FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients (opens in a new tab)

The door to enter the Tisch MSRCNY laboratory

03.07.2023

New Study Reveals New Potential Therapeutic Target for Experimental Multiple Sclerosis Treatment (opens in a new tab)

an organoid

02.08.2023

Researchers Create Novel Human Brain Model to Understand and Replicate Stem Cell Dysregulation in Multiple Sclerosis (opens in a new tab)

Hallway in a medical center

02.06.2023

Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes (opens in a new tab)

scientists working

08.09.2022

New Research Finds MS Patients Had Strong T-Cell Activation In Response to COVID-19 Vaccination (opens in a new tab)

Updates from the Lab

See More from the Lab

A young girl proudly holds up her Bugged Out t-shirt

05.18.2026

From Bugged Out to Giving Back

How One Woman’s Creativity and Passion are Funding MS Research

Organoids at Tisch MSRCNY

03.24.2026

New Publication Revealing Key Driver Behind Myelin Repair Failure in Progressive MS

Read our latest article, published in Frontiers in Cellular Neuroscience!

20 Year Anniversary Press

03.11.2026

Multiple Sclerosis Center Marks 20 Years of Research and Clinical Breakthroughs Thanks to Unprecedented Business Model

During MS Awareness Month, a Groundbreaking Research-and-Care Model Looks Back on 20 Years of Firsts

A large group of scientists attends a plenary session at ISSCR

07.30.2026

Inside the World's Leading Stem Cell Science Conference

Dr. Harris discusses the ISSCR 2026 Annual Meeting

Media Requests

For interviews, multimedia assets, and other media requests, contact our Communications Manager.

Send an Email